… -1 and Middle East respiratory syndrome (MERS) viruses, no vaccine … current development of SARS-CoV-2vaccines and address issues relevant to devising a safe and effective vaccine…
J Zhang, H Zeng, J Gu, H Li, L Zheng, Q Zou - Vaccines, 2020 - mdpi.com
… As a matter of fact, most of SARS-CoV-2 subunit vaccines currently under development use … was also used in the development of SARS-CoV and MERS-CoVvaccines. For example, …
A Awadasseid, Y Wu, Y Tanaka… - International journal of …, 2021 - ncbi.nlm.nih.gov
… the current status of vaccinedevelopment against clinically relevant SARS-CoV-2 strains, anticipating that such attempts would help create efficacious and sage SARS-CoV-2vaccines. …
… SARS-CoV-2 with a focus on vaccinedevelopment and its challenges. Vaccines are being rapidly developed … the development of vaccines against rapidly emerging viruses. Importantly, …
Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
… against this rapidly emerging virus or other similar pathogens in the future. In this … vaccine development initiatives by different companies, the potential strategies adopted for vaccine …
… as rapidly as possible to control COVID-19, which requires international … for the development of mRNA-based SARS-CoV-2vaccines and the current status of the mRNA-1273 vaccine. …
Y Dong, T Dai, Y Wei, L Zhang, M Zheng… - Signal transduction and …, 2020 - nature.com
… of therapeutic vaccines candidates against SARS-CoV-2. … confronted with during the development of vaccines. We also … the development of therapeutic methods against COVID-19. …
Y Dong, T Dai, B Wang, L Zhang, LH Zeng… - … and Targeted Therapy, 2021 - nature.com
… coronavirus disease 2019 (COVID-19). To halt the pandemic, multiple SARS-CoV-2vaccines have been developed … With novel SARS-CoV-2 variants emerging and circulating widely, …
Q Gao, L Bao, H Mao, L Wang, K Xu, M Yang, Y Li… - Science, 2020 - science.org
… as influenza virus and poliovirus (7, 8). To develop preclinical in vitro neutralization and challenge models for a candidate SARS-CoV-2vaccine, we isolated SARS-CoV-2 strains from …